This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (78)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Neurology  • Alzheimer Disease  • Schizophrenia  • Alert me on articles by topic

A Postmortem Neuropathologic Study of 100 Cases

Dushyant P. Purohit, MD; Daniel P. Perl, MD; Vahram Haroutunian, PhD; Peter Powchik, MD; Michael Davidson, MD; Kenneth L. Davis, MD

Arch Gen Psychiatry. 1998;55:205-211.

Background  Clinical studies suggest that severe cognitive impairment is common among elderly patients with schizophrenia who reside in long-stay psychiatric institutions; however, previous autopsy-based neuropathologic investigations have provided conflicting results about the occurrence of Alzheimer disease (AD) in elderly patients with schizophrenia. We report the results of a comprehensive neuropathologic study performed to identify AD and other dementing neurodegenerative diseases in elderly patients with schizophrenia.

Methods  A neuropathologic examination was performed on 100 consecutive autopsy brain specimens of patients aged 52 to 101 years (mean, 76.5 years). A cognitive assessment of these cases was also done by employing the Clinical Dementia Rating Scale. For comparison, we included 47 patients with nonschizophrenic psychiatric disorders from the same psychiatric hospital and 50 age-matched control subjects.

Results  Although 72% of the patients with schizophrenia showed cognitive impairment, AD was diagnosed in only 9% of the patients and other dementing diseases were diagnosed in only 4% of the patients. The degree of senile plaques or neurofibrillary tangles was not different in the group with schizophrenia compared with the age-matched controls or the group with nonschizophrenic psychiatric disorders. The higher Clinical Dementia Rating Scale scores lacked correlation with neuropathologic evidence of dementing disorders. In the 87 cases lacking a neuropathologic diagnosis of AD or other dementing disorders, the mean (±SD) Clinical Dementia Rating Scale score was 2.21 (±1.14), with 43 of the cases scoring 3 or higher (indicating severe, profound, or terminal cognitive impairment).

Conclusions  This study provides evidence that elderly patients with schizophrenia are not inordinately prone to the development of AD or to increased senile plaques or neurofibrillary tangle formation in the brain. Other dementing neurodegenerative disorders are also uncommon. The cognitive impairment in elderly patients with schizophrenia must, therefore, be related to some alternative mechanisms.

From the Neuropathology Division, Departments of Pathology (Drs Purohit and Perl) and Psychiatry (Drs Haroutunian, Powchik, Davidson, and Davis), Mount Sinai Medical Center, New York, NY.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive Impairment in Schizophrenia: A Life Span Perspective
O'Donnell
AM J ALZHEIMERS DIS OTHER DEMEN 2007;22:398-405.
ABSTRACT  

Long-term course of cognitive impairment in schizophrenia
MORRISON et al.
Br. J. Psychiatry 2006;189:556-557.
ABSTRACT | FULL TEXT  

Long-term outcome of late-onset schizophrenia: 5-year follow-up study
BRODATY et al.
Br. J. Psychiatry 2003;183:213-219.
ABSTRACT | FULL TEXT  

Amyloid {beta} Pathology in Alzheimer's Disease and Schizophrenia
Religa et al.
Am. J. Psychiatry 2003;160:867-872.
ABSTRACT | FULL TEXT  

Are Late-Onset Schizophrenia Spectrum Disorders Neurodegenerative Conditions? Annual Rates of Change on Two Dementia Measures
Palmer et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:45-52.
ABSTRACT | FULL TEXT  

Implications for Altered Glutamate and GABA Metabolism in the Dorsolateral Prefrontal Cortex of Aged Schizophrenic Patients
Gluck et al.
Am. J. Psychiatry 2002;159:1165-1173.
ABSTRACT | FULL TEXT  

Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia.
Woodruff-Pak and Gould
Behav Cogn Neurosci Rev 2002;1:5-20.
ABSTRACT  

Postmortem Assessment of Thalamic Nuclear Volumes in Subjects With Schizophrenia
Byne et al.
Am. J. Psychiatry 2002;159:59-65.
ABSTRACT | FULL TEXT  

N-Methyl-D-Aspartic Acid Receptor Expression in the Dorsolateral Prefrontal Cortex of Elderly Patients With Schizophrenia
Dracheva et al.
Am. J. Psychiatry 2001;158:1400-1410.
ABSTRACT | FULL TEXT  

Six-Year Follow-Up Study of Cognitive and Functional Status Across the Lifespan in Schizophrenia: A Comparison With Alzheimer's Disease and Normal Aging
Friedman et al.
Am. J. Psychiatry 2001;158:1441-1448.
ABSTRACT | FULL TEXT  

Dementia as a complication of schizophrenia
de Vries et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:588-596.
ABSTRACT | FULL TEXT  

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
Hakak et al.
Proc. Natl. Acad. Sci. USA 2001;98:4746-4751.
ABSTRACT | FULL TEXT  

Increased Neocortical Neurofibrillary Tangle Density in Subjects With Alzheimer Disease and Psychosis
Farber et al.
Arch Gen Psychiatry 2000;57:1165-1173.
ABSTRACT | FULL TEXT  

Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus
Howard et al.
Am. J. Psychiatry 2000;157:172-178.
ABSTRACT | FULL TEXT  

The neuropathology of schizophrenia: A critical review of the data and their interpretation
Harrison
Brain 1999;122:593-624.
ABSTRACT | FULL TEXT  

Senile Degeneration and Cognitive Impairment in Chronic Schizophrenia
Dwork et al.
Am. J. Psychiatry 1998;155:1536-1543.
ABSTRACT | FULL TEXT